Watchlist Price Alert

ReShape Lifesciences Inc. (RSLS)

NASDAQ: RSLS · Real-Time Price · USD

2.83

0.31 (12.30%)

At close: Jun 16, 2025, 3:59 PM

2.76

-2.30%

Pre-market: Jun 17, 2025, 04:07 AM EDT

ReShape Lifesciences Income Statement

Financials in USD. Fiscal year is January - December.

Fiscal Year	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020	FY 2019	FY 2018	FY 2017	FY 2016
Period Ending	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021	Dec 31, 2020	Dec 31, 2019	Dec 31, 2018	Dec 31, 2017	Dec 31, 2016
Revenue	8.01M	8.68M	11.24M	13.6M	11.3M	15.09M	606.71K	1.29M	786.66K
Cost of Revenue	2.95M	3.13M	4.44M	5.25M	5.04M	5.78M	164.3K	936.39K	431.48K
Gross Profit	5.06M	5.55M	6.8M	8.35M	6.26M	9.3M	442.41K	350.77K	355.18K
Operating Income	-6.67M	-14.64M	-27.08M	-27.75M	-12.46M	-15.89M	-38.55M	-31.41M	-22.8M
Interest Income	14K	n/a	113K	832K	2.05M	451K	n/a	1.07K	5.84K
Pretax Income	-7.09M	-11.34M	-46.59M	-62.04M	-21.81M	-75.1M	-38.71M	-36.13M	-23.36M
Net Income	-7.13M	-11.39M	-46.21M	-61.93M	-21.63M	-74.21M	-81.15M	-33.82M	-23.36M
Selling & General & Admin	9.92M	17.87M	31.34M	33.58M	15.22M	22.07M	19.26M	25.98M	17.98M
Research & Development	1.8M	2.31M	2.54M	2.52M	3.5M	3.12M	5.72M	5.78M	5.17M
Other Expenses	n/a	n/a	11K	23.5M	306K	-1.34M	-10.64K	-652	n/a
Operating Expenses	11.72M	20.19M	33.88M	36.1M	18.72M	25.19M	24.98M	31.76M	23.15M
Interest Expense	n/a	n/a	113K	832K	2.05M	451K	12.38K	3.87K	4.1M
Selling & Marketing Expenses	2.99M	7.55M	14.09M	9.16M	4.69M	4.85M	5.24M	n/a	n/a
Cost & Expenses	14.67M	23.32M	38.32M	41.35M	23.76M	30.98M	25.15M	32.7M	23.58M
Income Tax Expense	39K	52K	-380K	-106K	-181K	-893K	-3.45M	-2.31M	3.96M
Shares Outstanding (Basic)	515.57K	102.7K	7.32K	3.77K	1.35K	1.62K	218.81	192.14	48.53
Shares Outstanding (Diluted)	515.57K	102.7K	7.32K	3.77K	1.35K	1.62K	218.81	192.14	48.53
EPS (Basic)	-13.83	-110.88	-6.32K	-16.44K	-48.19K	-137.17K	-370.88K	-176.01K	-481.39K
EPS (Diluted)	-13.83	-110.88	-6.32K	-16.44K	-48.19K	-137.17K	-370.88K	-176.01K	-481.39K
EBITDA	-6.67M	-14.48M	-24.93M	-60.62M	-18.09M	-17.22M	-36.97M	-34.39M	-19.5M
EBIT	-6.67M	-14.64M	-27.08M	-62.59M	-19.76M	-23.29M	-37.15M	-32.78M	-19.99M
Depreciation & Amortization	n/a	154K	2.15M	1.97M	1.67M	894K	581K	330K	192K